Delivery Order SPE2DB20D2104-SPE2DB24FT21F
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,620.17, is for the supply of Vraylar 4.5 mg capsules. The contract is a firm fixed-price delivery order and has an ultimate completion date of April 10, 2025. It is not associated with any set-aside requirements. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,389.89 fixed-price contract is for the delivery of Vraylar 3 mg capsules, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,475.99 contract is for the supply of Vraylar 1.5 mg capsules, a specialty medication. The order has an ultimate completion date of October 16, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,188.07 firm-fixed-price contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vraylar 4.5 mg capsules. The contract has a firm fixed price of $2,753.44 and an ultimate completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,232.60, is for the delivery of Vraylar 1.5 mg capsules. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,403.29 contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of June 18, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,941.41, is for the supply of Vraylar 3 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,858.07 firm fixed-price contract is for the supply of Vraylar 4.5 mg capsules. The contract has an ultimate completion date of October 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,675.13, is for the delivery of Vraylar 1.5 mg capsules. The contract is a firm fixed-price delivery order with a performance period ending on December 31, 2024. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT21FDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $2,656.83 and has an ultimate completion date of March 26, 2024. It is not designated as a set-aside contract. The contract provides for the delivery of Vraylar 6 mg capsules, a prescription medication used to treat certain mental health conditions. As an Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical, AmerisourceBergen is a key supplier of pharmaceutical products and medical supplies to support military healthcare programs. This specific delivery order is part of the company's larger $999,999,999 IDC with the DLA, which runs through November 2026 and covers a comprehensive range of critical medical commodities across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/25/24 |